We are live on
!
Find out more
NC
Naman Capital Portfolio holdings
AUM
$323M
1-Year Est. Return
37.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+37.1%
3 Year Est. Return
+89.87%
5 Year Est. Return
+144.41%
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$2.95M
(+2.9%)
Cap. Flow
-$2.29M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
89.69%
Holding
13
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.88% |
| 2 | Technology | 19.5% |
| 3 | Miscellaneous | 14.95% |
| 4 | Consumer Staples | 11.15% |
| 5 | Financials | 7.59% |
Similar funds
ILI
WFS
GM
FWP
UCB
SG
RHP
NWMG
Naman Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Naman Capital held 13 positions worth $104M, up 2.9% from $101M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 0%. Naman Capital opened no new positions and made no exits, leaving the 13-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Miscellaneous.
- Naman Capital's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $2.29M.
- Naman Capital's ten largest holdings make up 90% of its $104M portfolio in Q4 2019.
- Naman Capital opened 0 new positions and closed 0 in Q4 2019.
- Naman Capital's portfolio value rose 2.9% quarter-over-quarter to $104M.
Based on Naman Capital's 13F filing for Q4 2019, filed 7 Oct 2022.